BofA

BofA Sees Positive Outlook for Novartis and GSK With Upcoming Milestones

The pharma sector is walking into 2025 with fresh momentum, and two big names are getting extra attention. Bank of America (BofA) recently shared a positive outlook on Novartis and GSK, pointing to several major milestones expected in the coming months. These updates matter because both companies are entering a crucial phase in their research pipelines and commercial plans.

Continue Reading on Meyka

This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.

Read Full Article →

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *